{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:49:01Z","timestamp":1790387341488,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.clnu.2006.01.016","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T11:19:02Z","timestamp":1148037542000},"page":"319-329","source":"Crossref","is-referenced-by-count":41,"title":["ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"J.","family":"Ockenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Grimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jonkers-Schuitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Macallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"S\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.269.6.729","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"269","year":"1993","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0899-9007(99)00083-0","article-title":"Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients","volume":"15","author":"Schwenk","year":"1999","journal-title":"Nutrition"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2006.01.016_bib3","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/375894","article-title":"Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting","volume":"37","author":"Wanke","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00042560-199511000-00009","article-title":"Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators","volume":"10","author":"Palenicek","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"Suppl 3","key":"10.1016\/j.clnu.2006.01.016_bib5","first-page":"S197","article-title":"HIV-associated Lipodystrophy Syndrome","volume":"14","author":"Mauss","year":"2000","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.clnu.2006.01.016_bib6","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1210\/jc.2002-020892","article-title":"Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure","volume":"87","author":"van","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clnu.2006.01.016_bib7","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/jc.2003-030985","article-title":"Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients","volume":"89","author":"van","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9407","key":"10.1016\/j.clnu.2006.01.016_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/00365540410019381","article-title":"Impact of switching antiretroviral therapy on lipodystrophy and other metabolic complications: a review","volume":"36","author":"Hansen","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"10.1016\/j.clnu.2006.01.016_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2006.01.016_bib12","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1086\/367561","article-title":"Weight loss and wasting in patients infected with human immunodeficiency virus","volume":"36","author":"Grinspoon","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.clnu.2006.01.016_bib13","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.81.11.4051","article-title":"Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.clnu.2006.01.016_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.clnu.2006.01.016_bib15","first-page":"20","article-title":"Bioelectrical impedance analysis as a predictor of survival in patients with the human immunodeficiency virus\u2014infection","volume":"9","author":"Ott","year":"1995","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00042560-199503010-00004","article-title":"Incidence and prognostic value of undernutrition and wasting in human immunodeficiency virus-infected outpatients","volume":"8","author":"Suttmann","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"11\u201312","key":"10.1016\/j.clnu.2006.01.016_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0899-9007(99)00210-5","article-title":"Undernutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients","volume":"15","author":"Melchior","year":"1999","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1086\/314027","article-title":"Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy","volume":"31","author":"Wanke","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 12","key":"10.1016\/j.clnu.2006.01.016_bib19","first-page":"S23","article-title":"Weight loss, wasting, and survival in HIV-positive patients: current strategies","volume":"13","author":"Tang","year":"2003","journal-title":"AIDS Read"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis\u2014part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2006.01.016_bib21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","article-title":"Bioelectrical impedance analysis\u2014part I: review of principles and methods","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ajcn\/72.2.496","article-title":"Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment","volume":"72","author":"Schwenk","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnu.2006.01.016_bib23","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/00002030-200012010-00012","article-title":"Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy","volume":"14","author":"Gerard","year":"2000","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib24","first-page":"507","article-title":"Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial","volume":"9","author":"Chlebowski","year":"1993","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.clnu.2006.01.016_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2362.2000.00591.x","article-title":"Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients","volume":"30","author":"Berneis","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.clnu.2006.01.016_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002030-199801000-00007","article-title":"A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study","volume":"12","author":"Pichard","year":"1998","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0002-8223(96)00156-3","article-title":"Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support","volume":"96","author":"Suttmann","year":"1996","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"10.1016\/j.clnu.2006.01.016_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-129-1-199807010-00005","article-title":"Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial","volume":"129","author":"Grinspoon","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clnu.2006.01.016_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ajcn\/53.1.149","article-title":"Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome","volume":"53","author":"Kotler","year":"1991","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.clnu.2006.01.016_bib30","first-page":"2059","article-title":"A multicenter case-controlled study of percutaneous endoscopic gastrostomy in HIV-seropositive patients","volume":"88","author":"Cappell","year":"1993","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib31","first-page":"36","article-title":"Percutaneous endoscopic gastrostomy feeding in HIV disease","volume":"8","author":"Brantsma","year":"1991","journal-title":"Aust J Adv Nurs"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1258\/0956462961917474","article-title":"An evaluation of percutaneous endoscopic gastrostomy feeding in AIDS","volume":"7","author":"Dowling","year":"1996","journal-title":"Int J STD AIDS"},{"issue":"11","key":"10.1016\/j.clnu.2006.01.016_bib33","first-page":"579","article-title":"Oral supplements in HIV-infected patients with chronic wasting. A prospective trial","volume":"89","author":"Burger","year":"1994","journal-title":"Med Klin"},{"key":"10.1016\/j.clnu.2006.01.016_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0261-5614(93)90048-9","article-title":"Home enteral nutrition in patients with acquired immunodeficiency syndrome","volume":"12","author":"S\u00fcttmann","year":"1993","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnu.2006.01.016_bib35","first-page":"1817","article-title":"Percutaneous endoscopic gastrostomy in AIDS and control patients: risks and outcome","volume":"91","author":"Ockenga","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.clnu.2006.01.016_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0026-0495(95)90009-8","article-title":"Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss","volume":"44","author":"Selberg","year":"1995","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00002030-199604000-00005","article-title":"Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. The French Multicenter Total Parenteral Nutrition Cooperative Group Study","volume":"10","author":"Melchior","year":"1996","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib38","first-page":"336","article-title":"Improved survival by home total parenteral nutrition in AIDS patients: follow-up of a controlled randomized prospective trial","volume":"12","author":"Melchior","year":"1998","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib39","first-page":"267","article-title":"Nutritional supplementation according to energy and protein requirements in malnourished HIV-infected patients","volume":"52","author":"Charlin","year":"2002","journal-title":"Arch Latinoam Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0261-5614(99)80018-1","article-title":"Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial","volume":"18","author":"Schwenk","year":"1999","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-8223(98)00099-6","article-title":"A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients","volume":"98","author":"Rabeneck","year":"1998","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.clnu.2006.01.016_bib42","series-title":"Dietary advice for illness-related undernutrition in adults (Cochrane review). The Cochrane Library","author":"Baldwin","year":"2004"},{"key":"10.1016\/j.clnu.2006.01.016_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002008","article-title":"Dietary advice for illness-related undernutrition in adults","volume":"CD002008","author":"Baldwin","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clnu.2006.01.016_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/014860710202600106","article-title":"Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial","volume":"26","author":"Keithley","year":"2002","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clnu.2006.01.016_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199507133330202","article-title":"Energy expenditure and wasting in human immunodeficiency virus infection","volume":"333","author":"Macallan","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0148607198022003120","article-title":"Comparison of total parenteral nutrition and an oral, semielemental diet on body composition, physical function, and nutrition-related costs in patients with malabsorption due to acquired immunodeficiency syndrome","volume":"22","author":"Kotler","year":"1998","journal-title":"J Parent Enter Nutr"},{"issue":"11\u201312","key":"10.1016\/j.clnu.2006.01.016_bib47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0899-9007(96)00221-3","article-title":"A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial","volume":"12","author":"Wanke","year":"1996","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib48","first-page":"367","article-title":"Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy","volume":"35","author":"Moyle","year":"2004","journal-title":"J AIDS"},{"issue":"5","key":"10.1016\/j.clnu.2006.01.016_bib49","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1210\/jc.82.5.1332","article-title":"Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clnu.2006.01.016_bib50","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/jc.83.8.2717","article-title":"Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clnu.2006.01.016_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archinte.164.8.897","article-title":"Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study","volume":"164","author":"Dolan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.clnu.2006.01.016_bib52","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(02)00441-3","article-title":"Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis","volume":"2","author":"Kong","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clnu.2006.01.016_bib53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting\u2014a randomized, placebo-controlled trial","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clnu.2006.01.016_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002030-200303280-00008","article-title":"Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting","volume":"17","author":"Hengge","year":"2003","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.clnu.2006.01.016_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00002030-199606001-00008","article-title":"Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection","volume":"10","author":"Gold","year":"1996","journal-title":"AIDS"},{"issue":"22","key":"10.1016\/j.clnu.2006.01.016_bib56","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199906033402207","article-title":"Treatments for wasting in patients with the acquired immunodeficiency syndrome","volume":"340","author":"Corcoran","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2006.01.016_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","article-title":"Megestrol acetate in patients with AIDS-related Cachexia","volume":"122","author":"Von Roenn","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J Pain Symptom Manage"},{"issue":"1345","key":"10.1016\/j.clnu.2006.01.016_bib59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1089\/08892220050140892","article-title":"Thalidomide for the treatment of AIDS-associated wasting","volume":"14","author":"Kaplan","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0148607100024003133","article-title":"Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study","volume":"24","author":"Clark","year":"2000","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1440-1746.1998.tb00648.x","article-title":"Percutaneous endoscopic gastrostomy feeding in AIDS","volume":"13","author":"Crotty","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"7214","key":"10.1016\/j.clnu.2006.01.016_bib62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/bmj.319.7214.881","article-title":"Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy","volume":"319","author":"Preclik","year":"1999","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-1999-13658","article-title":"Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial","volume":"31","author":"Gossner","year":"1999","journal-title":"Endoscopy"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00075197-200007000-00008","article-title":"Tuberculosis, undernutrition and wasting","volume":"3","author":"Schwenk","year":"2000","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1086\/313651","article-title":"A population-based survey of tuberculosis symptoms: how atypical are atypical presentations?","volume":"30","author":"Miller","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ajcn\/77.2.392","article-title":"Leptin and energy metabolism in pulmonary tuberculosis","volume":"77","author":"Schwenk","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2006.01.016_bib67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0035-9203(02)90103-3","article-title":"Moderate to severe undernutrition in patients with tuberculosis is a risk factor associated with early death","volume":"96","author":"Zachariah","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.clnu.2006.01.016_bib68","first-page":"363","article-title":"Undernutrition among tuberculosis patients in Harrow, England","volume":"42","author":"Onwubalili","year":"1988","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2006.01.016_bib69","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ajcn\/79.6.1006","article-title":"Nutrient partitioning during treatment of tuberculosis: gain in body fat mass but not in protein mass","volume":"79","author":"Schwenk","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/80.2.460","article-title":"A randomised controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting","volume":"80","author":"Paton","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clnu.2006.01.008","article-title":"Methodology for the development of the ESPEN Guidelines on Enteral Nutrition","volume":"25","author":"Sch\u00fctz","year":"2006","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2006.01.016_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clnu.2006.02.007","article-title":"Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, Definitions and General Topics","volume":"25","author":"Lochs","year":"2006","journal-title":"Clin Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561406000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561406000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T23:07:19Z","timestamp":1555628839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561406000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0261561406000367"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2006.01.016","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}